Metraipolis › archive › dc_9759d281c57f

mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes — Europe PMC PMID:41479562

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479562
DOI
10.32607/actanaturae.27707
License (as archived)
solo-consultazione
Archived
2026-11-09T16:27:05.009Z
SHA-256 of the archived text
9560f953fa8b42768157759104799d31c8dd97f392f2bbec0c7d13d8a6e13520
Stable URL of this page
https://metraipolis.com/documento/dc_9759d281c57f

How to cite

mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes — Europe PMC PMID:41479562 — Europe PMC (en), https://europepmc.org/article/MED/41479562 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9759d281c57f (Metraipolis archive dc_9759d281c57f, sha256 9560f953fa8b42768157759104799d31c8dd97f392f2bbec0c7d13d8a6e13520)
BibTeX
@misc{dc9759d281c57f,
  title = {mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes — Europe PMC PMID:41479562},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479562},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9759d281c57f; sha256 9560f953fa8b42768157759104799d31c8dd97f392f2bbec0c7d13d8a6e13520},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479562. Agents can read the archived copy with the MCP tool read_document.